Histone Deacetylase 2 Market, Global Outlook and Forecast 2022-2028

Histone Deacetylase 2 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281246 | No. of Pages: 75 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Histone Deacetylase 2 in global, including the following market information:
Global Histone Deacetylase 2 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Histone Deacetylase 2 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Histone Deacetylase 2 companies in 2021 (%)
The global Histone Deacetylase 2 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
RCY-1305 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Histone Deacetylase 2 include 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., GlaxoSmithKline Plc, HitGen LTD, Italfarmaco S.p.A., MEI Pharma, Inc. and Merck & Co., Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Histone Deacetylase 2 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Histone Deacetylase 2 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 2 Market Segment Percentages, by Type, 2021 (%)
    RCY-1305
    HG-3001
    CS-3158
    ACY-957
    Others
Global Histone Deacetylase 2 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 2 Market Segment Percentages, by Application, 2021 (%)
    Colon Cancer
    Non-Hodgkin Lymphoma
    Alopecia
    Bladder Cancer
    Others
Global Histone Deacetylase 2 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 2 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Histone Deacetylase 2 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Histone Deacetylase 2 revenues share in global market, 2021 (%)
Key companies Histone Deacetylase 2 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Histone Deacetylase 2 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    4SC AG
    Acetylon Pharmaceuticals, Inc.
    Chipscreen Biosciences Ltd
    Curis, Inc.
    GlaxoSmithKline Plc
    HitGen LTD
    Italfarmaco S.p.A.
    MEI Pharma, Inc.
    Merck & Co., Inc.
    Rodin Therapeutics
    Sigma-Tau S.p.A.
    TetraLogic Pharmaceuticals
    Yungjin Pharm. Co., Ltd.
1 Introduction to Research & Analysis Reports
    1.1 Histone Deacetylase 2 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Histone Deacetylase 2 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Histone Deacetylase 2 Overall Market Size
    2.1 Global Histone Deacetylase 2 Market Size: 2021 VS 2028
    2.2 Global Histone Deacetylase 2 Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Histone Deacetylase 2 Sales: 2017-2028
3 Company Landscape
    3.1 Top Histone Deacetylase 2 Players in Global Market
    3.2 Top Global Histone Deacetylase 2 Companies Ranked by Revenue
    3.3 Global Histone Deacetylase 2 Revenue by Companies
    3.4 Global Histone Deacetylase 2 Sales by Companies
    3.5 Global Histone Deacetylase 2 Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Histone Deacetylase 2 Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Histone Deacetylase 2 Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Histone Deacetylase 2 Players in Global Market
        3.8.1 List of Global Tier 1 Histone Deacetylase 2 Companies
        3.8.2 List of Global Tier 2 and Tier 3 Histone Deacetylase 2 Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Histone Deacetylase 2 Market Size Markets, 2021 & 2028
        4.1.2 RCY-1305
        4.1.3 HG-3001
        4.1.4 CS-3158
        4.1.5 ACY-957
        4.1.6 Others
    4.2 By Type - Global Histone Deacetylase 2 Revenue & Forecasts
        4.2.1 By Type - Global Histone Deacetylase 2 Revenue, 2017-2022
        4.2.2 By Type - Global Histone Deacetylase 2 Revenue, 2023-2028
        4.2.3 By Type - Global Histone Deacetylase 2 Revenue Market Share, 2017-2028
    4.3 By Type - Global Histone Deacetylase 2 Sales & Forecasts
        4.3.1 By Type - Global Histone Deacetylase 2 Sales, 2017-2022
        4.3.2 By Type - Global Histone Deacetylase 2 Sales, 2023-2028
        4.3.3 By Type - Global Histone Deacetylase 2 Sales Market Share, 2017-2028
    4.4 By Type - Global Histone Deacetylase 2 Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Histone Deacetylase 2 Market Size, 2021 & 2028
        5.1.2 Colon Cancer
        5.1.3 Non-Hodgkin Lymphoma
        5.1.4 Alopecia
        5.1.5 Bladder Cancer
        5.1.6 Others
    5.2 By Application - Global Histone Deacetylase 2 Revenue & Forecasts
        5.2.1 By Application - Global Histone Deacetylase 2 Revenue, 2017-2022
        5.2.2 By Application - Global Histone Deacetylase 2 Revenue, 2023-2028
        5.2.3 By Application - Global Histone Deacetylase 2 Revenue Market Share, 2017-2028
    5.3 By Application - Global Histone Deacetylase 2 Sales & Forecasts
        5.3.1 By Application - Global Histone Deacetylase 2 Sales, 2017-2022
        5.3.2 By Application - Global Histone Deacetylase 2 Sales, 2023-2028
        5.3.3 By Application - Global Histone Deacetylase 2 Sales Market Share, 2017-2028
    5.4 By Application - Global Histone Deacetylase 2 Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Histone Deacetylase 2 Market Size, 2021 & 2028
    6.2 By Region - Global Histone Deacetylase 2 Revenue & Forecasts
        6.2.1 By Region - Global Histone Deacetylase 2 Revenue, 2017-2022
        6.2.2 By Region - Global Histone Deacetylase 2 Revenue, 2023-2028
        6.2.3 By Region - Global Histone Deacetylase 2 Revenue Market Share, 2017-2028
    6.3 By Region - Global Histone Deacetylase 2 Sales & Forecasts
        6.3.1 By Region - Global Histone Deacetylase 2 Sales, 2017-2022
        6.3.2 By Region - Global Histone Deacetylase 2 Sales, 2023-2028
        6.3.3 By Region - Global Histone Deacetylase 2 Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Histone Deacetylase 2 Revenue, 2017-2028
        6.4.2 By Country - North America Histone Deacetylase 2 Sales, 2017-2028
        6.4.3 US Histone Deacetylase 2 Market Size, 2017-2028
        6.4.4 Canada Histone Deacetylase 2 Market Size, 2017-2028
        6.4.5 Mexico Histone Deacetylase 2 Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Histone Deacetylase 2 Revenue, 2017-2028
        6.5.2 By Country - Europe Histone Deacetylase 2 Sales, 2017-2028
        6.5.3 Germany Histone Deacetylase 2 Market Size, 2017-2028
        6.5.4 France Histone Deacetylase 2 Market Size, 2017-2028
        6.5.5 U.K. Histone Deacetylase 2 Market Size, 2017-2028
        6.5.6 Italy Histone Deacetylase 2 Market Size, 2017-2028
        6.5.7 Russia Histone Deacetylase 2 Market Size, 2017-2028
        6.5.8 Nordic Countries Histone Deacetylase 2 Market Size, 2017-2028
        6.5.9 Benelux Histone Deacetylase 2 Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Histone Deacetylase 2 Revenue, 2017-2028
        6.6.2 By Region - Asia Histone Deacetylase 2 Sales, 2017-2028
        6.6.3 China Histone Deacetylase 2 Market Size, 2017-2028
        6.6.4 Japan Histone Deacetylase 2 Market Size, 2017-2028
        6.6.5 South Korea Histone Deacetylase 2 Market Size, 2017-2028
        6.6.6 Southeast Asia Histone Deacetylase 2 Market Size, 2017-2028
        6.6.7 India Histone Deacetylase 2 Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Histone Deacetylase 2 Revenue, 2017-2028
        6.7.2 By Country - South America Histone Deacetylase 2 Sales, 2017-2028
        6.7.3 Brazil Histone Deacetylase 2 Market Size, 2017-2028
        6.7.4 Argentina Histone Deacetylase 2 Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Histone Deacetylase 2 Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Histone Deacetylase 2 Sales, 2017-2028
        6.8.3 Turkey Histone Deacetylase 2 Market Size, 2017-2028
        6.8.4 Israel Histone Deacetylase 2 Market Size, 2017-2028
        6.8.5 Saudi Arabia Histone Deacetylase 2 Market Size, 2017-2028
        6.8.6 UAE Histone Deacetylase 2 Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 4SC AG
        7.1.1 4SC AG Corporate Summary
        7.1.2 4SC AG Business Overview
        7.1.3 4SC AG Histone Deacetylase 2 Major Product Offerings
        7.1.4 4SC AG Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.1.5 4SC AG Key News
    7.2 Acetylon Pharmaceuticals, Inc.
        7.2.1 Acetylon Pharmaceuticals, Inc. Corporate Summary
        7.2.2 Acetylon Pharmaceuticals, Inc. Business Overview
        7.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Major Product Offerings
        7.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.2.5 Acetylon Pharmaceuticals, Inc. Key News
    7.3 Chipscreen Biosciences Ltd
        7.3.1 Chipscreen Biosciences Ltd Corporate Summary
        7.3.2 Chipscreen Biosciences Ltd Business Overview
        7.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 2 Major Product Offerings
        7.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.3.5 Chipscreen Biosciences Ltd Key News
    7.4 Curis, Inc.
        7.4.1 Curis, Inc. Corporate Summary
        7.4.2 Curis, Inc. Business Overview
        7.4.3 Curis, Inc. Histone Deacetylase 2 Major Product Offerings
        7.4.4 Curis, Inc. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.4.5 Curis, Inc. Key News
    7.5 GlaxoSmithKline Plc
        7.5.1 GlaxoSmithKline Plc Corporate Summary
        7.5.2 GlaxoSmithKline Plc Business Overview
        7.5.3 GlaxoSmithKline Plc Histone Deacetylase 2 Major Product Offerings
        7.5.4 GlaxoSmithKline Plc Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.5.5 GlaxoSmithKline Plc Key News
    7.6 HitGen LTD
        7.6.1 HitGen LTD Corporate Summary
        7.6.2 HitGen LTD Business Overview
        7.6.3 HitGen LTD Histone Deacetylase 2 Major Product Offerings
        7.6.4 HitGen LTD Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.6.5 HitGen LTD Key News
    7.7 Italfarmaco S.p.A.
        7.7.1 Italfarmaco S.p.A. Corporate Summary
        7.7.2 Italfarmaco S.p.A. Business Overview
        7.7.3 Italfarmaco S.p.A. Histone Deacetylase 2 Major Product Offerings
        7.7.4 Italfarmaco S.p.A. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.7.5 Italfarmaco S.p.A. Key News
    7.8 MEI Pharma, Inc.
        7.8.1 MEI Pharma, Inc. Corporate Summary
        7.8.2 MEI Pharma, Inc. Business Overview
        7.8.3 MEI Pharma, Inc. Histone Deacetylase 2 Major Product Offerings
        7.8.4 MEI Pharma, Inc. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.8.5 MEI Pharma, Inc. Key News
    7.9 Merck & Co., Inc.
        7.9.1 Merck & Co., Inc. Corporate Summary
        7.9.2 Merck & Co., Inc. Business Overview
        7.9.3 Merck & Co., Inc. Histone Deacetylase 2 Major Product Offerings
        7.9.4 Merck & Co., Inc. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.9.5 Merck & Co., Inc. Key News
    7.10 Rodin Therapeutics
        7.10.1 Rodin Therapeutics Corporate Summary
        7.10.2 Rodin Therapeutics Business Overview
        7.10.3 Rodin Therapeutics Histone Deacetylase 2 Major Product Offerings
        7.10.4 Rodin Therapeutics Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.10.5 Rodin Therapeutics Key News
    7.11 Sigma-Tau S.p.A.
        7.11.1 Sigma-Tau S.p.A. Corporate Summary
        7.11.2 Sigma-Tau S.p.A. Histone Deacetylase 2 Business Overview
        7.11.3 Sigma-Tau S.p.A. Histone Deacetylase 2 Major Product Offerings
        7.11.4 Sigma-Tau S.p.A. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.11.5 Sigma-Tau S.p.A. Key News
    7.12 TetraLogic Pharmaceuticals
        7.12.1 TetraLogic Pharmaceuticals Corporate Summary
        7.12.2 TetraLogic Pharmaceuticals Histone Deacetylase 2 Business Overview
        7.12.3 TetraLogic Pharmaceuticals Histone Deacetylase 2 Major Product Offerings
        7.12.4 TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.12.5 TetraLogic Pharmaceuticals Key News
    7.13 Yungjin Pharm. Co., Ltd.
        7.13.1 Yungjin Pharm. Co., Ltd. Corporate Summary
        7.13.2 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Business Overview
        7.13.3 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Major Product Offerings
        7.13.4 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales and Revenue in Global (2017-2022)
        7.13.5 Yungjin Pharm. Co., Ltd. Key News
8 Global Histone Deacetylase 2 Production Capacity, Analysis
    8.1 Global Histone Deacetylase 2 Production Capacity, 2017-2028
    8.2 Histone Deacetylase 2 Production Capacity of Key Manufacturers in Global Market
    8.3 Global Histone Deacetylase 2 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Histone Deacetylase 2 Supply Chain Analysis
    10.1 Histone Deacetylase 2 Industry Value Chain
    10.2 Histone Deacetylase 2 Upstream Market
    10.3 Histone Deacetylase 2 Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Histone Deacetylase 2 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com